Recruiting Vasculitis Studies in Hamilton
Abatacept for the Treatment of Giant Cell Arteritis
This randomized, double-blind, placebo-controlled trial will seek to determine the efficacy of abatacept in GCA. To examine this objective, 62 eligible patients who have newly diagnosed or relapsing G...
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
This study will enroll male and female subjects who are 18 years of age or older with Eosinophilic Granulomatosis With Polyangiitis....
About Vasculitis Clinical Trials in Hamilton
Vasculitis refers to a group of disorders that involve inflammation of blood vessels, which can restrict blood flow and damage organs. Types include ANCA-associated vasculitis, giant cell arteritis, and Takayasu arteritis. Treatment typically involves corticosteroids and immunosuppressive medications.
There are currently 2 vasculitis clinical trials recruiting participants in Hamilton, NJ. These studies are seeking a combined 123 participants. Research is being sponsored by University of Pennsylvania, NS Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Vasculitis Clinical Trials in Hamilton — FAQ
Are there vasculitis clinical trials in Hamilton?
Yes, there are 2 vasculitis clinical trials currently recruiting in Hamilton, NJ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hamilton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hamilton research site will contact you about next steps.
Are clinical trials in Hamilton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hamilton studies also compensate for your time and travel.
What vasculitis treatments are being tested?
The 2 active trials in Hamilton are testing new therapies including novel drugs, biologics, and treatment approaches for vasculitis.
Data updated March 2, 2026 from ClinicalTrials.gov